EVSBY yields 3.70% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, EVSBY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EVSBY + JNJ for your $10,000?
EVS Broadcast Equipment SA provides live video technology for broadcast and media productions worldwide. The company offers live replay and story telling products, including live replay and highlights systems, cloud-based super slow-motion services, and graphics effects; live production, replay, studio production, and software-based studio servers; web-based asset management platform, live PAM suite, achieve digitization and content delivery, media workflow management, and connected archive and transcoding services; and broadcast control and monitoring systems and control panels. It also provides IP router products; real time media processors; media storage systems; production switchers; multi-camera review systems; camera automation systems; and live production systems. In addition, the company offers support services, such as download area, assistance, support portal, and learning center. Further, it provides solutions in the areas of live sports images, entertainment shows, and news content. The company was incorporated in 1994 and is headquartered in Seraing, Belgium.
Full EVSBY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.